A detailed history of Arizona State Retirement System transactions in Alnylam Pharmaceuticals, Inc. stock. As of the latest transaction made, Arizona State Retirement System holds 36,240 shares of ALNY stock, worth $8.54 Million. This represents 0.06% of its overall portfolio holdings.

Number of Shares
36,240
Previous 34,736 4.33%
Holding current value
$8.54 Million
Previous $8.44 Million 18.1%
% of portfolio
0.06%
Previous 0.06%

Shares

19 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 12, 2024

BUY
$233.81 - $287.01 $351,650 - $431,663
1,504 Added 4.33%
36,240 $9.97 Million
Q2 2024

Aug 05, 2024

BUY
$143.31 - $247.0 $31,384 - $54,093
219 Added 0.63%
34,736 $8.44 Million
Q1 2024

May 07, 2024

BUY
$146.51 - $198.2 $23,588 - $31,910
161 Added 0.47%
34,517 $5.16 Million
Q4 2023

Jan 24, 2024

BUY
$151.41 - $196.57 $57,990 - $75,286
383 Added 1.13%
34,356 $6.58 Million
Q3 2023

Nov 06, 2023

BUY
$170.77 - $211.65 $26,127 - $32,382
153 Added 0.45%
33,973 $6.02 Million
Q2 2023

Aug 01, 2023

SELL
$185.01 - $212.05 $360,214 - $412,861
-1,947 Reduced 5.44%
33,820 $6.42 Million
Q1 2023

Apr 27, 2023

BUY
$182.66 - $235.53 $327,509 - $422,305
1,793 Added 5.28%
35,767 $7.16 Million
Q4 2022

Feb 07, 2023

BUY
$185.53 - $241.31 $148,980 - $193,771
803 Added 2.42%
33,974 $8.07 Million
Q3 2022

Nov 07, 2022

SELL
$138.54 - $232.0 $52,506 - $87,928
-379 Reduced 1.13%
33,171 $6.64 Million
Q2 2022

Jul 28, 2022

BUY
$120.42 - $169.29 $31,068 - $43,676
258 Added 0.77%
33,550 $4.89 Million
Q1 2022

May 04, 2022

BUY
$127.18 - $173.91 $118,658 - $162,258
933 Added 2.88%
33,292 $5.44 Million
Q4 2021

Feb 04, 2022

SELL
$159.56 - $209.29 $100,363 - $131,643
-629 Reduced 1.91%
32,359 $5.49 Million
Q3 2021

Nov 12, 2021

SELL
$169.75 - $207.73 $13,919 - $17,033
-82 Reduced 0.25%
32,988 $6.23 Million
Q2 2021

Aug 02, 2021

SELL
$128.63 - $176.89 $55,053 - $75,708
-428 Reduced 1.28%
33,070 $5.61 Million
Q1 2021

May 06, 2021

BUY
$126.83 - $175.69 $30,819 - $42,692
243 Added 0.73%
33,498 $4.73 Million
Q4 2020

Jan 28, 2021

SELL
$122.97 - $147.0 $206,958 - $247,401
-1,683 Reduced 4.82%
33,255 $4.32 Million
Q3 2020

Nov 05, 2020

BUY
$121.19 - $165.49 $1.06 Million - $1.44 Million
8,713 Added 33.22%
34,938 $5.09 Million
Q2 2020

Aug 04, 2020

BUY
$104.21 - $156.44 $59,191 - $88,857
568 Added 2.21%
26,225 $3.88 Million
Q1 2020

May 05, 2020

BUY
$93.12 - $133.99 $2.39 Million - $3.44 Million
25,657 New
25,657 $2.79 Million

Others Institutions Holding ALNY

About ALNYLAM PHARMACEUTICALS, INC.


  • Ticker ALNY
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 123,028,000
  • Market Cap $29B
  • Description
  • Alnylam Pharmaceuticals, Inc., a biopharmaceutical company, focuses on discovering, developing, and commercializing novel therapeutics based on ribonucleic acid interference. The company's pipeline of investigational RNAi therapeutics focuses on genetic medicines, cardio-metabolic diseases, hepatic infectious diseases, and central nervous system...
More about ALNY
Track This Portfolio

Track Arizona State Retirement System Portfolio

Follow Arizona State Retirement System and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Arizona State Retirement System, based on Form 13F filings with the SEC.

News

Stay updated on Arizona State Retirement System with notifications on news.